Carboxyl terminus of Hsp70-interacting protein (CHIP) is required to modulate cardiac hypertrophy and attenuate autophagy during exercise

Cell Biochemistry and Function

Volumn 31, Issue 8, 2013, Pages 724-735

  Willis, Monte S ^a   Min, Jin Na ^a   Wang, Shaobin ^a   Mcdonough, Holly ^a   Lockyer, Pamela ^a   Wadosky, Kristine M ^a   Patterson, Cam ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Autophagy; Cardiac hypertrophy; CHIP; Heart; IGF 1 signalling; Ubiquitin ligase

Indexed keywords

CARBOXYL TERMINUS OF HSP70 INTERACTING PROTEIN; PROTEIN KINASE B; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; CHIP PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME INHIBITION; EXERCISE; HEART FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RUNNING; SELECTIVE AUTOPHAGY; SIGNAL TRANSDUCTION; 129 MOUSE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CARDIOMEGALY; CHEMISTRY; DRUG EFFECTS; METABOLISM;

MUS;

ANIMALS; AUTOPHAGY; CARDIOMEGALY; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; PHYSICAL CONDITIONING, ANIMAL; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 84897080893     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2962     Document Type: Article

References (100)

1. Jiang J, Ballinger CA, Wu Y, et al. CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation. J Biol Chem 2001; 276: 42938-42944.
2. Cyr DM, Hohfeld J, Patterson C. Protein quality control: U-box-containing E3 ubiquitin ligases join the fold. Trends Biochem Sci 2002; 27: 368-375.
3. Connell P, Ballinger CA, Jiang J, et al. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol 2001; 3: 93-96.
4. Petrucelli L, Dickson D, Kehoe K, et al. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum Mol Genet 2004; 13: 703-714.
5. Dickey CA, Kamal A, Lundgren K, et al. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J Clin Invest 2007; 117: 648-658.
6. Dickey CA, Patterson C, Dickson D, Petrucelli L. Brain CHIP: removing the culprits in neurodegenerative disease. Trends Mol Med 2007; 13: 32-38.
7. Zhang C, Xu Z, He XR, Michael LH, Patterson C. CHIP, a cochaperone/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice. Am J Physiol Heart Circ Physiol 2005; 288: H2836-H2842.
8. Arndt V, Dick N, Tawo R, et al. Chaperone-assisted selective autophagy is essential for muscle maintenance. Curr Biol 2010; 20: 143-148.
9. Massey AC, Zhang C, Cuervo AM. Chaperone-mediated autophagy in aging and disease. Curr Top Dev Biol 2006; 73: 205-235.
10. Golbidi S, Laher I. Molecular mechanisms in exercise-induced cardioprotection. Cardiol Res Pract 2011; 2011: 972807.
11. Chen CY, Hsu HC, Lee BC, et al. Exercise training improves cardiac function in infarcted rabbits: involvement of autophagic function and fatty acid utilization. Eur J Heart Fail 2010; 12: 323-330.
12. Gottlieb RA, Mentzer RM. Autophagy during cardiac stress: joys and frustrations of autophagy. Annu Rev Physiol 2010; 72: 45-59.
13. Cao DJ, Gillette TG, Hill JA. Cardiomyocyte autophagy: remodeling, repairing, and reconstructing the heart. Curr Hypertens Rep 2009; 11: 406-411.
14. Ma X, Liu H, Foyil SR, Godar RJ, Weinheimer CJ, Diwan A. Autophagy is impaired in cardiac ischemia-reperfusion injury. Autophagy 2012; 8: 1394-1396.
15. Ma X, Liu H, Foyil SR, et al. Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation 2012; 125: 3170-3181.
16. Huang C, Yitzhaki S, Perry CN, et al. Autophagy induced by ischemic preconditioning is essential for cardioprotection. J Cardiovasc Transl Res 2010; 3: 365-373.
17. Hausenloy DJ, Ong SB, Yellon DM. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol 2009; 104: 189-202.
18. Hamacher-Brady A, Brady NR, Gottlieb RA. Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem 2006; 281: 29776-29787.
19. Huang C, Andres AM, Ratliff EP, Hernandez G, Lee P, Gottlieb RA. Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS One 2011; 6: e20975.
20. Tannous P, Zhu H, Johnstone JL, et al. Autophagy is an adaptive response in desmin-related cardiomyopathy. Proc Natl Acad Sci U S A 2008; 105: 9745-9750.
21. Glembotski CC. Endoplasmic reticulum stress in the heart. Circ Res 2007; 101: 975-984.
22. Cox LS, Mattison JA. Increasing longevity through caloric restriction or rapamycin feeding in mammals: common mechanisms for common outcomes? Aging Cell 2009; 8: 607-613.
23. Lerman I, Harrison BC, Freeman K, et al. Genetic variability in forced and voluntary endurance exercise performance in seven inbred mouse strains. J Appl Physiol 2002; 92: 2245-2255.
24. Allen DL, Harrison BC, Maass A, Bell ML, Byrnes WC, Leinwand LA. Cardiac and skeletal muscle adaptations to voluntary wheel running in the mouse. J Appl Physiol 2001; 90: 1900-1908.
25. Massett MP, Berk BC. Strain-dependent differences in responses to exercise training in inbred and hybrid mice. Am J Physiol Regul Integr Comp Physiol 2005; 288: R1006-R1013.
26. Miyazaki M, Esser KA. Cellular mechanisms regulating protein synthesis and skeletal muscle hypertrophy in animals. J Appl Physiol 2009; 106: 1367-1373.
27. Mackenzie MG, Hamilton DL, Murray JT, Baar K. mVps34 is activated by an acute bout of resistance exercise. Biochem Soc Trans 2007; 35: 1314-1316.
28. Ilback NG, Friman G, Squibb RL, Johnson AJ, Balentine DA, Beisel WR. The effect of exercise and fasting on the myocardial protein and lipid metabolism in experimental bacterial myocarditis. Acta Pathol Microbiol Immunol Scand A 1984; 92: 195-204.
29. Min JN, Whaley RA, Sharpless NE, Lockyer P, Portbury AL, Patterson C. CHIP deficiency decreases longevity, with accelerated aging phenotypes accompanied by altered protein quality control. Mol Cell Biol 2008; 28: 4018-4025.
30. Willis MS, Ike C, Li L, Wang DZ, Glass DJ, Patterson C. Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo. Circ Res 2007; 100: 456-459.
31. Konhilas JP, Widegren U, Allen DL, Paul AC, Cleary A, Leinwand LA. Loaded wheel running and muscle adaptation in the mouse. Am J Physiol Heart Circ Physiol 2005; 289: H455-H465.
32. Li HH, Willis MS, Lockyer P, et al. Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins. J Clin Invest 2007; 117: 3211-3223.
33. Wysong A, Couch M, Shadfar S, et al. NF-kappaB inhibition protects against tumor-induced cardiac atrophy in vivo. Am J Pathol 2011; 178: 1059-1068.
34. Willis MS, Schisler JC, Li L, et al. Cardiac muscle ring finger-1 increases susceptibility to heart failure in vivo. Circ Res 2009; 105: 80-88.
35. Claycomb WC, Lanson NA, Jr, Stallworth BS, et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 1998; 95: 2979-2984.
36. Su H, Li F, Ranek MJ, Wei N, Wang X. COP9 signalosome regulates autophagosome maturation. Circulation 2011; 124: 2117-2128.
37. Su H, Wang X. Autophagy and p62 in cardiac protein quality control. Autophagy 2011; 7: 1382-1383.
38. Ballinger CA, Connell P, Wu Y, et al. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol 1999; 19: 4535-4545.
39. Dai Q, Qian SB, Li HH, et al. Regulation of the cytoplasmic quality control protein degradation pathway by BAG2. J Biol Chem 2005; 280: 38673-38681.
40. Crippa V, Sau D, Rusmini P, et al. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). Hum Mol Genet 2010; 19: 3440-3456.
41. Gurusamy N, Das DK. Is autophagy a double-edged sword for the heart? Acta Physiol Hung 2009; 96: 267-276.
42. Chiang HL, Dice JF. Peptide sequences that target proteins for enhanced degradation during serum withdrawal. J Biol Chem 1988; 263: 6797-6805.
43. Cuervo AM, Gomes AV, Barnes JA, Dice JF. Selective degradation of annexins by chaperone-mediated autophagy. J Biol Chem 2000; 275: 33329-33335.
44. Dice JF. Peptide sequences that target cytosolic proteins for lysosomal proteolysis. Trends Biochem Sci 1990; 15: 305-309.
45. Roszek K, Gniot-Szulzycka J. Lysosomal membrane glycoprotein lamp2a-receptor for chaperone-mediated degradation of cytosolic proteins. Postepy Biochem 2005; 51: 88-94.
46. Cuervo AM, Dice JF. Regulation of LAMP2A levels in the lysosomal membrane. Traffic 2000; 1: 570-583.
47. Cuervo AM, Dice JF. Unique properties of LAMP2A compared to other LAMP2 isoforms. J Cell Sci 2000; 113(Pt 24): 4441-4450.
48. McMullen JR, Izumo S. Role of the insulin-like growth factor 1 (IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy. Novartis Found Symp 2006; 274: 90-111; discussion 111-117, 152-115, 272-116.
49. McMullen JR, Shioi T, Huang WY, et al. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. J Biol Chem 2004; 279: 4782-4793.
50. Dorn GW, 2nd, Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 2005; 115: 527-537.
51. Gosselin H, Beliveau L, Burelle Y, Clement R, Lajoie C, El-Helou V, Calderone A. Disparate regulation of signaling proteins after exercise and myocardial infarction. Med Sci Sports Exerc 2006; 38: 455-462.
52. Dickey CA, Koren J, Zhang YJ, et al. Akt and CHIP coregulate tau degradation through coordinated interactions. Proc Natl Acad Sci U S A 2008; 105: 3622-3627.
53. Guo W, Kamiya K, Yasui K, Kodama I, Toyama J. Alpha1-adrenoceptor agonists and IGF-1, myocardial hypertrophic factors, regulate the Kv1.5K+channel expression differentially in cultured newborn rat ventricular cells. Pflugers Arch 1998; 436: 26-32.
54. Long CS, Kariya K, Karns L, Simpson PC. Trophic factors for cardiac myocytes. J Hypertens Suppl 1990; 8: S219-S224.
55. Liu J, Liu Z, Huang F, Xing Z, Wang H, Li Z. Pioglitazone inhibits hypertrophy induced by high glucose and insulin in cultured neonatal rat cardiomyocytes. Pharmazie 2007; 62: 925-929.
56. van der Vos KE, Eliasson P, Proikas-Cezanne T, et al. Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy. Nat Cell Biol 2012; 14: 829-837.
57. Sandri M. FOXOphagy path to inducing stress resistance and cell survival. Nat Cell Biol 2012; 14: 786-788.
58. Naito AT, Okada S, Minamino T, et al. Promotion of CHIP-mediated p53 degradation protects the heart from ischemic injury. Circ Res 2010; 106: 1692-1702.
59. Kobayashi S, Mao K, Zheng H, et al. Diminished GATA4 protein levels contribute to hyperglycemia-induced cardiomyocyte injury. J Biol Chem 2007; 282: 21945-21952.
60. Nemchenko A, Chiong M, Turer A, Lavandero S, Hill JA. Autophagy as a therapeutic target in cardiovascular disease. J Mol Cell Cardiol 2011; 51: 584-593.
61. Nakai A, Yamaguchi O, Takeda T, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 2007; 13: 619-624.
62. Taneike M, Yamaguchi O, Nakai A, et al. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy 2010; 6: 600-606.
63. Salminen A, Vihko V. Autophagic response to strenuous exercise in mouse skeletal muscle fibers. Virchows Arch B Cell Pathol Incl Mol Pathol 1984; 45: 97-106.
64. R120G cardiomyocytes. Circ Res 2011; 109: 151-160.
65. Pattison JS, Robbins J. Autophagy and proteotoxicity in cardiomyocytes. Autophagy 2011; 7: 1259-1260.
66. Pattison JS, Sanbe A, Maloyan A, Osinska H, Klevitsky R, Robbins J. Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure. Circulation 2008; 117: 2743-2751.
67. DeBosch B, Treskov I, Lupu TS, et al. Akt1 is required for physiological cardiac growth. Circulation 2006; 113: 2097-2104.
68. Ibebunjo C, Eash JK, Li C, Ma Q, Glass DJ. Voluntary running, skeletal muscle gene expression, and signaling inversely regulated by orchidectomy and testosterone replacement. Am J Physiol Endocrinol Metab 2011; 300: E327-E340.
69. DeBosch B, Sambandam N, Weinheimer C, Courtois M, Muslin AJ. Akt2 regulates cardiac metabolism and cardiomyocyte survival. J Biol Chem 2006; 281: 32841-32851.
70. Muslin AJ, DeBosch B. Role of Akt in cardiac growth and metabolism. Novartis Found Symp 2006; 274: 118-126; discussion 126-131, 152-115, 272-116.
71. Kemi OJ, Ceci M, Wisloff U, et al. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy. J Cell Physiol 2008; 214: 316-321.
72. Sanbe A, Osinska H, Saffitz JE, et al. Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. Proc Natl Acad Sci U S A 2004; 101: 10132-10136.
73. Wang X, Osinska H, Dorn GW, 2nd, et al. Mouse model of desmin-related cardiomyopathy. Circulation 2001; 103: 2402-2407.
74. Wang X, Osinska H, Klevitsky R, et al. Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice. Circ Res 2001; 89: 84-91.
75. Wang X, Klevitsky R, Huang W, Glasford J, Li F, Robbins J. AlphaB-crystallin modulates protein aggregation of abnormal desmin. Circ Res 2003; 93: 998-1005.
76. Decker RS, Wildenthal K. Lysosomal alterations in hypoxic and reoxygenated hearts. I. Ultrastructural and cytochemical changes. Am J Pathol 1980; 98: 425-444.
77. Elmore SP, Qian T, Grissom SF, Lemasters JJ. The mitochondrial permeability transition initiates autophagy in rat hepatocytes. FASEB J 2001; 15: 2286-2287.
78. Nowikovsky K, Reipert S, Devenish RJ, Schweyen RJ. Mdm38 protein depletion causes loss of mitochondrial K+/H+exchange activity, osmotic swelling and mitophagy. Cell Death Differ 2007; 14: 1647-1656.
79. Priault M, Salin B, Schaeffer J, Vallette FM, di Rago JP, Martinou JC. Impairing the bioenergetic status and the biogenesis of mitochondria triggers mitophagy in yeast. Cell Death Differ 2005; 12: 1613-1621.
80. Twig G, Elorza A, Molina AJ, et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 2008; 27: 433-446.
81. Carreira RS, Lee Y, Ghochani M, Gustafsson AB, Gottlieb RA. Cyclophilin D is required for mitochondrial removal by autophagy in cardiac cells. Autophagy 2010; 6: 462-472.
82. Narendra D, Tanaka A, Suen DF, Youle RJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 2008; 183: 795-803.
83. Weiss JN, Korge P, Honda HM, Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ Res 2003; 93: 292-301.
84. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999; 341(Pt 2): 233-249.
85. Xue L, Fletcher GC, Tolkovsky AM. Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol Cell Neurosci 1999; 14: 180-198.
86. Xue L, Fletcher GC, Tolkovsky AM. Mitochondria are selectively eliminated from eukaryotic cells after blockade of caspases during apoptosis. Curr Biol 2001; 11: 361-365.
87. Gottlieb RA, Carreira RS. Autophagy in health and disease. 5. Mitophagy as a way of life. Am J Physiol Cell Physiol 2010; 299: C203-C210.
88. van Bilsen M, Smeets PJ, Gilde AJ, van der Vusse GJ. Metabolic remodelling of the failing heart: the cardiac burn-out syndrome? Cardiovasc Res 2004; 61: 218-226.
89. Stanley WC, Chandler MP. Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Fail Rev 2002; 7: 115-130.
90. Lee Y, Lee HY, Gustafsson AB. Regulation of autophagy by metabolic and stress signaling pathways in the heart. J Cardiovasc Pharmacol 2012; 60: 118-124.
91. Horowitz JD, Chirkov YY, Kennedy JA, Sverdlov AL. Modulation of myocardial metabolism: an emerging therapeutic principle. Curr Opin Cardiol 2010; 25: 329-334.
92. Beer M, Seyfarth T, Sandstede J, et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol 2002; 40: 1267-1274.
93. Hill JA, Olson EN. Cardiac plasticity. N Engl J Med 2008; 358: 1370-1380.
94. Tsukamoto O, Minamino T, Okada K, et al. Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice. Biochem Biophys Res Commun 2006; 340: 1125-1133.
95. Wang ZV, Ferdous A, Hill JA. 2013 Cardiomyocyte autophagy: metabolic profit and loss. Heart Fail Rev 2012, Sep 30. DOI: 10.1007/s10741-012-9350-y
96. Matsui Y, Takagi H, Qu X, et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 2007; 100: 914-922.
97. Zhu H, Tannous P, Johnstone JL, et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest 2007; 117: 1782-1793.
98. Cao DJ, Wang ZV, Battiprolu PK, et al. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci U S A 2011; 108: 4123-4128.
99. Sinha S, Levine B. The autophagy effector Beclin 1: a novel BH3-only protein. Oncogene 2008; 27(Suppl 1): S137-S148.
100. Rifki OF, Hill JA. Cardiac autophagy: good with the bad. J Cardiovasc Pharmacol 2012; 60: 248-252.